By Najat Kantouar N. Brown Group, the U.K. online retailer, announced a pretax loss for the current period due to restructuring costs and lower online orders. This decline in performance can be attributed to cautious consumer behavior and unseasonable weather conditions. The company reported a pretax loss of £4.1 million ($5 million), reflecting £4.5 million in restructuring … [Read more...] about N. Brown Group Reports Loss Due to Restructuring Costs and Consumer Behavior
Forex News
U.S. Crude-Oil Inventories Set to See Slight Increase
According to a survey conducted by The Wall Street Journal, U.S. crude-oil inventories are expected to experience a small uptick from the previous week, as indicated by data from the Energy Department. Nine analysts and traders were polled, with their estimates revealing that U.S. commercial crude-oil stockpiles are projected to have increased by 900,000 barrels for the week … [Read more...] about U.S. Crude-Oil Inventories Set to See Slight Increase
Promising Results for Annovis Bio’s Phase 2/3 Study on Alzheimer’s Disease
By Adam L. Cataldo Annovis Bio, a clinical-stage drug platform company based in Berwyn, Pa., recently announced positive findings from an independent statistical group regarding its Phase 2/3 study on Alzheimer's disease. The company revealed that there is no need to include additional patients, allowing the study to continue as planned. Market Reaction and Future … [Read more...] about Promising Results for Annovis Bio’s Phase 2/3 Study on Alzheimer’s Disease
Inflation Woes for Senior Citizens
The latest inflation figures from the United States government are cause for concern, particularly for senior citizens. Social Security beneficiaries will only receive a 3.2% cost-of-living adjustment to their monthly checks starting in January, according to the program's administrators. This means that retired workers, who receive an average monthly check of $1,840, will only … [Read more...] about Inflation Woes for Senior Citizens
Tempest Therapeutics Stock Drops Over 50% After Rapid Surge
Shares of microcap oncology company Tempest Therapeutics Inc. (TPST) plunged more than 50% on Thursday, following a remarkable 40-fold gain in the previous day. The surge in trading prompted a temporary halt due to volatility. This significant increase in stock value was triggered by the release of new study results for Tempest's investigational treatment, TPST-1120, for liver … [Read more...] about Tempest Therapeutics Stock Drops Over 50% After Rapid Surge
